What is the recommended treatment for panic disorder?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Panic Disorder

The recommended first-line treatment for panic disorder is a combination of cognitive behavioral therapy (CBT) and a selective serotonin reuptake inhibitor (SSRI), with sertraline being a preferred medication option due to its proven efficacy and favorable side effect profile. 1, 2

First-Line Treatment Options

Pharmacotherapy

  • SSRIs are the preferred first-line medication:
    • Sertraline: Start at 25-50 mg daily, may increase to 50-200 mg daily 3, 2
    • Other effective SSRIs include paroxetine and fluoxetine 1, 4
    • SNRIs (particularly venlafaxine) are also effective first-line options 1

Psychotherapy

  • Cognitive Behavioral Therapy (CBT) is the most effective psychological treatment 1
    • Individual therapy is preferred over group therapy for moderate to severe panic disorder
    • Should include exposure techniques, cognitive restructuring, and relaxation training
    • Typically requires 12-16 sessions for optimal results

Treatment Algorithm

  1. For mild panic disorder:

    • Start with CBT alone
    • If inadequate response after 4-6 weeks, add an SSRI
  2. For moderate to severe panic disorder:

    • Begin simultaneously with both CBT and an SSRI
    • Initial SSRI dose should be lower than used for depression (e.g., sertraline 25 mg daily) to minimize initial activation symptoms
    • Gradually titrate to effective dose over 2-4 weeks
  3. Assess response after 4-6 weeks:

    • If responding, continue treatment
    • If partial response, increase SSRI dose
    • If no response, switch to another SSRI or SNRI

Second-Line Treatment Options

  • SNRIs (if not used first-line):

    • Venlafaxine: Particularly effective for GAD with panic 1
    • Duloxetine: Consider when comorbid pain conditions exist 1
  • Tricyclic antidepressants (TCAs):

    • As effective as SSRIs but with more side effects 4, 5
    • Examples: imipramine, clomipramine
  • Benzodiazepines (short-term use only):

    • Alprazolam: Effective for acute symptom relief 6, 7
    • Dosage: Start at 0.25-0.5 mg three times daily, may increase to 1-4 mg daily in divided doses 6
    • Caution: Risk of dependence, withdrawal, and tolerance; not recommended for long-term use or in patients with history of substance abuse 6, 4

Treatment Duration and Monitoring

  • Continue effective medication for at least 6-12 months after symptom remission 1
  • Monitor for side effects, particularly during initial treatment phase
  • When discontinuing, taper gradually to avoid withdrawal symptoms:
    • SSRIs: Taper over 2-4 weeks
    • Benzodiazepines: Taper very slowly over months to avoid withdrawal symptoms 6

Special Populations

  • Elderly patients: Start with lower doses and titrate more slowly 1
  • Pregnant/lactating women: SSRIs may be used with caution when benefits outweigh risks 1
  • Children/adolescents (6-18 years): SSRIs are first-line, with monitoring for suicidal ideation 1

Lifestyle Modifications

  • Regular exercise, particularly in the morning
  • Adequate sleep hygiene
  • Limiting caffeine and alcohol intake
  • Mindfulness and meditation practices
  • Establishing consistent daily routines 1

Common Pitfalls to Avoid

  1. Starting SSRIs at full dose: Begin with lower doses to minimize activation symptoms
  2. Using benzodiazepines as first-line or long-term treatment: Reserve for short-term use due to dependence risk 6, 7
  3. Discontinuing medications abruptly: Always taper gradually to prevent withdrawal symptoms
  4. Inadequate treatment duration: Continue treatment for 6-12 months after remission to prevent relapse 1
  5. Failing to address comorbid conditions: Depression, other anxiety disorders, and substance use disorders frequently co-occur with panic disorder and may require additional targeted interventions 1

By following this evidence-based approach, most patients with panic disorder can achieve significant symptom improvement and better quality of life.

References

Guideline

Treatment of Anxiety Disorders

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Sertraline in the treatment of panic disorder.

Drugs of today (Barcelona, Spain : 1998), 2009

Research

Pharmacological treatment of panic disorder.

Modern trends in pharmacopsychiatry, 2013

Research

Treatment of panic disorder.

American family physician, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.